Clinical Scorecard: Comparative Analysis of Metabolic and Inflammatory Profiles in Ugandan Youth with HIV on Dolutegravir from Urban and Rural Settings

At a Glance

Key Highlights

• Urban YPHIV exhibit higher BMI, insulin resistance (HOMA-IR), total cholesterol, and LDL compared to rural YPHIV.
• Rural YPHIV have elevated inflammatory markers including sCD14, sCD163, hsCRP, IL-6, TNFRI, and LBP, with sCD14 remaining significantly elevated after adjustments.
• ART with Dolutegravir and viral suppression do not fully normalize immune activation and gut barrier dysfunction in YPHIV, especially in rural settings.

Guideline-Based Recommendations

Diagnosis

• Screen YPHIV for metabolic risk factors including insulin resistance and dyslipidemia.
• Assess inflammatory and microbial translocation markers where feasible to evaluate immune activation.

Management

• Maintain viral suppression with ART regimens including Dolutegravir.
• Address socioeconomic and environmental factors contributing to inflammation and metabolic risk.
• Consider targeted interventions to reduce chronic inflammation and prevent cardiovascular comorbidities.

Monitoring & Follow-up

• Regular monitoring of viral load to ensure suppression (<400 copies/mL).
• Periodic assessment of metabolic parameters (BMI, lipids, HOMA-IR).
• Monitor inflammatory biomarkers in research or specialized settings to guide risk stratification.

Risks

• Persistent immune activation despite viral suppression may increase risk of cardiovascular disease and other comorbidities.
• Rural YPHIV face higher inflammatory burden possibly related to poverty and environmental exposures.
• Delayed diagnosis and treatment initiation in rural areas may worsen outcomes.

Patient & Prescribing Data

Youth with perinatally acquired HIV on stable ART including Tenofovir, Lamivudine, and Dolutegravir

Dolutegravir-based ART achieves viral suppression in majority but does not fully resolve immune activation or metabolic disturbances, highlighting need for comprehensive care.

Clinical Best Practices

• Incorporate socioeconomic and environmental context in management plans for YPHIV.
• Promote inclusion of rural populations in research to better understand regional differences in HIV-related comorbidities.
• Focus on early diagnosis and sustained viral suppression to mitigate long-term metabolic and inflammatory complications.
• Use multidisciplinary approaches addressing nutrition, infection control, and psychosocial support.

References

• WHO STEPS Instrument
• Demographic and Health Surveys Wealth Index